Power3 Medical Products, Inc.

Research agreement signed to ID early biomarkers for breast cancer

Published in Oncology Business Week, October 24th, 2004

Power3 Medical Products, Inc., (OTCBB: PWRM) announced the signing of a research agreement with Mercy Women's Center, Oklahoma City, Oklahoma, and the collaboration with Dr. Alan Hollingsworth, research director at Mercy Women's Center Medical on the identification of protein biomarkers for the early indication of breast cancer in blood serum.

Under this agreement, Mercy Women's Center will provide Power3 Medical up to 600 blood serum samples from normal subjects and subjects with various stages of breast cancer.

According to Hollingsworth, "Such a test would revolutionize screening and diagnosis of breast cancer, yet very little attention has been...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week

Source: Oncology Business Week (2004-10-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry